Watanabe M - Search Results

1

Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting.

Yuan J, Watanabe M, Suliman M, Qureshi AR, Axelsson J, Bárány P, Heimbürger O, Stenvinkel P, Lindholm B. Yuan J, et al. Among authors: watanabe m. Nephrol Dial Transplant. 2015 Feb;30(2):274-82. doi: 10.1093/ndt/gft265. Epub 2013 Aug 24. Nephrol Dial Transplant. 2015. PMID: 23975839

2

Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality.

Watanabe M, Suliman ME, Qureshi AR, Garcia-Lopez E, Bárány P, Heimbürger O, Stenvinkel P, Lindholm B. Watanabe M, et al. Am J Clin Nutr. 2008 Jun;87(6):1860-6. doi: 10.1093/ajcn/87.6.1860. Am J Clin Nutr. 2008. PMID: 18541578 Free article.

3

Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients.

Xu H, Watanabe M, Qureshi AR, Heimbürger O, Bárány P, Anderstam B, Eriksson M, Stenvinkel P, Lindholm B. Xu H, et al. Among authors: watanabe m. Perit Dial Int. 2015 Mar-Apr;35(2):206-15. doi: 10.3747/pdi.2013.00259. Epub 2014 Mar 1. Perit Dial Int. 2015. PMID: 24584621 Free PMC article.

4

Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease.

Dai L, Watanabe M, Qureshi AR, Mukai H, Machowska A, Heimbürger O, Barany P, Lindholm B, Stenvinkel P. Dai L, et al. Among authors: watanabe m. Eur J Intern Med. 2019 Oct;68:60-65. doi: 10.1016/j.ejim.2019.07.035. Epub 2019 Aug 9. Eur J Intern Med. 2019. PMID: 31402276

5

Associations between the CYBA 242C/T and the MPO -463G/A polymorphisms, oxidative stress and cardiovascular disease in chronic kidney disease patients.

Grahl DA, Axelsson J, Nordfors L, Heimburger O, Bárány P, Gao YZ, Qureshi AR, Kato S, Watanabe M, Suliman M, Riella MC, Lindholm B, Stenvinkel P, Pecoits-Filho R. Grahl DA, et al. Among authors: watanabe m. Blood Purif. 2007;25(2):210-8. doi: 10.1159/000100419. Blood Purif. 2007. PMID: 17337886 Clinical Trial.

6

Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors.

Valli A, Suliman ME, Meert N, Vanholder R, Lindholm B, Stenvinkel P, Watanabe M, Barany P, Alvestrand A, Anderstam B. Valli A, et al. Among authors: watanabe m. Clin Chim Acta. 2007 Apr;379(1-2):87-94. doi: 10.1016/j.cca.2006.12.026. Epub 2007 Jan 16. Clin Chim Acta. 2007. PMID: 17292872

7

Oxidized high-density lipoprotein is associated with protein-energy wasting in maintenance hemodialysis patients.

Honda H, Ueda M, Kojima S, Mashiba S, Suzuki H, Hosaka N, Hirai Y, Nakamura M, Nagai H, Kato N, Mukai M, Watanabe M, Takahashi K, Shishido K, Akizawa T. Honda H, et al. Among authors: watanabe m. Clin J Am Soc Nephrol. 2010 Jun;5(6):1021-8. doi: 10.2215/CJN.06110809. Epub 2010 Apr 15. Clin J Am Soc Nephrol. 2010. PMID: 20395357 Free PMC article.

8

Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients.

Ashikaga E, Honda H, Suzuki H, Hosaka N, Hirai Y, Sanada D, Nakamura M, Nagai H, Matsumoto K, Kato N, Mukai M, Watanabe M, Takahashi K, Shishido K, Akizawa T. Ashikaga E, et al. Among authors: watanabe m. Ther Apher Dial. 2010 Jun;14(3):315-22. doi: 10.1111/j.1744-9987.2009.00796.x. Ther Apher Dial. 2010. PMID: 20609185

9

Assessment of myeloperoxidase and oxidative alpha1-antitrypsin in patients on hemodialysis.

Honda H, Ueda M, Kojima S, Mashiba S, Hirai Y, Hosaka N, Suzuki H, Mukai M, Watanabe M, Takahashi K, Shishido K, Akizawa T. Honda H, et al. Among authors: watanabe m. Clin J Am Soc Nephrol. 2009 Jan;4(1):142-51. doi: 10.2215/CJN.02280508. Epub 2009 Jan 7. Clin J Am Soc Nephrol. 2009. PMID: 19129321 Free PMC article.

10

Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.

Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T; LANDMARK Investigators and Committees. Ogata H, et al. JAMA. 2021 May 18;325(19):1946-1954. doi: 10.1001/jama.2021.4807. JAMA. 2021. PMID: 34003226 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,164 results

Search Page

Filters